PubMed HealthSearch

PubMed · 8303321

Difficult management problems in fulminant hepatic failure.

Abstract

The management of each FHF patient offers valuable opportunities to learn about the disease process, but the severity of this illness leaves little room for mishaps or omissions. FHF is a true medical emergency, like cardiogenic shock or acute renal failure. Hepatologists and transplant surgeons should train and teach their team, including ICU staff and house officers, in the basic aspects of FHF management. Furthermore, we strongly favor the creation of "FHF groups" in transplantation centers frequently caring for FHF patients. This group brings together hepatologists, transplant surgeons, ICU staff, nurses, neurologists, transplant coordinators, social workers, and others to design an FHF management protocol, periodically update and refine it, and develop a local consensus on the management of the many issues surrounding the care of the patient with FHF.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Muñoz. 1993. Difficult management problems in fulminant hepatic failure.. https://doi.org/10.1055/s-2007-1007368

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prevention of severe hepatic injury by interferon-alpha in chronic active hepatitis lacking HBeAg (mutant strain) in a patient with malignant lymphoma.

Multidrug chemotherapy with concomitant interferon (IFN)-alpha was performed in a patient with chronic hepatitis lacking the hepatitis Be antigen and malignant lymphoma (ML). Levels of trans-aminases and DNA polymerase (DNA-P) values increased after the fifth course of chemotherapy. Therapy with IFN-alpha for 9 weeks induced a remission in liver disease and complete remission of ML was obtained with subsequent chemotherapy. It was possible to prevent severe liver damage by administering IFN immediately after the elevation of DNA-P. Early introduction of IFN may be effective in the prevention of fulminant hepatic failure from hepatitis from a precore mutant after chemotherapy.

Hepatic Encephalopathy